Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
about
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyPrimary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyPrimary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapyVenous thromboembolic diseaseElevated risk of venous thromboembolic events in patients with inflammatory myopathiesAnticoagulants in cancerBiomolecular markers of cancer-associated thromboembolismThromboprophylaxis guidelines in cancer with a primary focus on ambulatory patients receiving chemotherapy: a review from the Southern Network on Adverse Reactions (SONAR)Risk of venous thromboembolism in patients with cancer: a systematic review and meta-analysisPulmonary embolism as the initial presentation of testicular carcinoma.Rationale and design of PROSPECT-CONKO 004: a prospective, randomized trial of simultaneous pancreatic cancer treatment with enoxaparin and chemotherapy).Venous access catheter-related thrombosis in patients with cancer.Clinical characteristics of pulmonary embolism with underlying malignancyHospitalisation for venous thromboembolism in cancer patients and the general population: a population-based cohort study in Denmark, 1997-2006Wilms tumor gene (WT1) peptide-based cancer vaccine combined with gemcitabine for patients with advanced pancreatic cancer.Variation in the risk of venous thromboembolism in people with colorectal cancer: a population-based cohort study from EnglandPrimary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy.Cisplatin chemotherapy (without erythropoietin) and risk of life-threatening thromboembolic events in carcinoma of the uterine cervix: the tip of the iceberg? A review of the literature.Risk factors and incidence of thromboembolic events (TEEs) in older men and women with breast cancerDeep vein thrombosis in cancer: the scale of the problem and approaches to management.Incidence of Venous Thromboembolism in cancer patients treated with Cisplatin based chemotherapy - a cohort study.Impact of venous thromboembolism on mortality of elderly Medicare patients with stage III colon cancerApproach to chemotherapy-associated thrombosis.Increased risk of venous thromboembolism in patients with acute leukaemia.Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study.Management of venous thromboembolism in patients with cancer: role of dalteparin.Thrombin inhibition and cyclophosphamide synergistically block tumor progression and metastasisRisk of venous thromboembolism in hospitalised cancer patients in England-a cohort studyDoxorubicin-induced vascular toxicity--targeting potential pathways may reduce procoagulant activityHypercoagulability and lung cancer.Epidemiology of cancer-related venous thromboembolism.Prevention and treatment of venous thromboembolism with low-molecular-weight heparins: Clinical implications of the recent European guidelines.The incidence and risk of venous thromboembolism associated with cancer and nonsurgical cancer treatment.Venous thromboembolism (VTE) in patients with cancer: epidemiology and risk factors.Standard or extended-duration prophylaxis in medical patients? A review of the evidence.How to prevent, treat, and overcome current clinical challenges of VTE.Management of venous thromboembolism in patients with cancer.Primary venous thromboembolism prophylaxis in ambulatory cancer patients.Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive.Treating patients with cancer and acute venous thromboembolism.
P2860
Q24194257-9A17A895-2837-4886-B483-A27E86719796Q24203644-99922CD5-7ACA-4112-9005-6FC5FC01F564Q24235587-43A45B61-39A5-4613-9B98-8D71EDE2093BQ24631121-F3F2BC27-CF3D-48C6-9C40-E8E10AAB926EQ26746904-C887785B-2AE0-4E33-B283-90A14ED47052Q26825228-5D9F0EAC-1C44-481F-911A-748894378CF7Q26865716-F0982A01-DD32-45D0-BCB7-7E430998307AQ26995284-450284D5-91F0-4A27-AFDE-729D7AFCE141Q27005043-D397D70C-C4CC-4D28-B4F8-AC9C44A96E0FQ30445009-FE94ECD2-1089-407F-BF2C-501737362217Q33389637-34926836-06EF-4E4D-B53F-AF6BC1A6E84EQ33408419-3DA274C9-B992-4F00-A42E-5DDCEF072D78Q33691627-2ED415B5-E2CB-4AEB-9B0E-15B129B68298Q34250240-2AFFE21C-1CA0-4F7F-B7CF-1BB9007C2AE6Q34498299-5CEACB65-99C9-4E11-A214-325FD873C549Q34503151-3EA3F768-3474-4EA6-8D1C-B0D933A8B0F0Q34546366-65CE4EE8-B6D9-4630-ADC5-9C30EB6FB852Q34899063-BBAB8FBC-1E19-404F-A4C5-FE9949EDE0F0Q35432469-25F7DC8A-0A40-4450-B9B6-05EBE0DF536BQ36085302-2DBD7EAD-6EF2-4B86-985E-20F0BEDA3435Q36250714-4323DCA6-4209-43DC-8EFA-07F4ED4A8D47Q36251473-15981BAB-DC89-4FC2-B1E1-597B42407413Q36304793-4E3FE60F-D4D6-4D2D-A8F3-11B563C91F0BQ36613611-4148EF15-B315-4C02-88BE-19D34ED3BE0BQ36625144-80592AC1-8770-4433-8B74-62AB505EB892Q36812767-DE36D44D-7E56-4BCA-85E4-5EF91CAE1881Q36843779-04909FAE-9B02-416D-8AA2-E14459A04D9CQ37129682-EB60DDDF-AE85-43DE-882F-49DB1B28262AQ37188135-A033982C-51ED-40E9-A863-056869154889Q37188554-3C96D064-B6AC-4B98-BBCB-8934EB04C340Q37242472-7DE06F50-C9B8-42F5-A317-C927ECE83FEFQ37265242-D973FFF5-CF9E-40B2-8818-1981DC7E6F0FQ37374557-D32571C0-A1F0-4287-95FD-D4F51780ACD0Q37416512-6C1A5681-09CD-4EAE-AAF8-7E4A9182A7CEQ37873397-B498BDD1-FF39-42CB-887A-ED6C24661D0CQ37903951-F6764DA6-2F2F-468B-BCA7-A1510847B302Q37903957-62B821A1-FD8F-449B-98FE-0955F60622DCQ38079522-BFE4648F-7B26-4E44-B14D-1AE902CB2069Q38381351-894A0E5E-4E3C-4254-8167-23C2F8F05FF9Q38647343-48E54298-E0A6-4DF5-8925-7ADC30EDAADE
P2860
Symptomatic venous thromboembolism in cancer patients treated with chemotherapy: an underestimated phenomenon.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年学术文章
@wuu
2004年学术文章
@zh
2004年学术文章
@zh-cn
2004年学术文章
@zh-hans
2004年学术文章
@zh-my
2004年学术文章
@zh-sg
2004年學術文章
@yue
2004年學術文章
@zh-hant
name
Symptomatic venous thromboembo ...... an underestimated phenomenon.
@en
Symptomatic venous thromboembo ...... an underestimated phenomenon.
@nl
type
label
Symptomatic venous thromboembo ...... an underestimated phenomenon.
@en
Symptomatic venous thromboembo ...... an underestimated phenomenon.
@nl
prefLabel
Symptomatic venous thromboembo ...... an underestimated phenomenon.
@en
Symptomatic venous thromboembo ...... an underestimated phenomenon.
@nl
P2093
P1476
Symptomatic venous thromboembo ...... an underestimated phenomenon.
@en
P2093
Dick J Richel
Hans-Martin M B Otten
Joost Mathijssen
Marcel Soesan
Marijke Inghels
Martin H Prins
P304
P356
10.1001/ARCHINTE.164.2.190
P407
P577
2004-01-01T00:00:00Z